Annual EBIT
$46.81 M
+$81.42 M+235.24%
31 December 2023
Summary:
ANI Pharmaceuticals annual earnings before interest & taxes is currently $46.81 million, with the most recent change of +$81.42 million (+235.24%) on 31 December 2023. During the last 3 years, it has risen by +$63.32 million (+383.54%). ANIP annual EBIT is now at all-time high.ANIP EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$29.17 M
-$31.54 M-1331.19%
30 September 2024
Summary:
ANI Pharmaceuticals quarterly earnings before interest & taxes is currently -$29.17 million, with the most recent change of -$31.54 million (-1331.19%) on 30 September 2024. Over the past year, it has dropped by -$47.08 million (-262.86%). ANIP quarterly EBIT is now -197.43% below its all-time high of $29.93 million, reached on 31 March 2024.ANIP Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
$9.83 M
-$47.08 M-82.73%
30 September 2024
Summary:
ANI Pharmaceuticals TTM earnings before interest & taxes is currently $9.83 million, with the most recent change of -$47.08 million (-82.73%) on 30 September 2024. Over the past year, it has dropped by -$32.07 million (-76.54%). ANIP TTM EBIT is now -85.30% below its all-time high of $66.89 million, reached on 31 March 2024.ANIP TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANIP EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +235.2% | -262.9% | -76.5% |
| 3 y3 years | +383.5% | -529.5% | +156.0% |
| 5 y5 years | +34.5% | -499.8% | -69.2% |
ANIP EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +206.1% | -197.4% | at low | -85.3% | +114.9% |
| 5 y | 5 years | at high | +206.1% | -197.4% | at low | -85.3% | +114.9% |
| alltime | all time | at high | +191.9% | -197.4% | at low | -85.3% | +114.9% |
ANI Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$29.17 M(-1331.2%) | $9.83 M(-82.7%) |
| June 2024 | - | $2.37 M(-92.1%) | $56.91 M(-14.9%) |
| Mar 2024 | - | $29.93 M(+347.3%) | $66.89 M(+42.9%) |
| Dec 2023 | $46.81 M(-235.2%) | $6.69 M(-62.6%) | $46.81 M(+11.7%) |
| Sept 2023 | - | $17.91 M(+45.0%) | $41.90 M(+120.2%) |
| June 2023 | - | $12.35 M(+25.2%) | $19.03 M(-448.0%) |
| Mar 2023 | - | $9.86 M(+454.6%) | -$5.47 M(-84.2%) |
| Dec 2022 | -$34.61 M(-21.6%) | $1.78 M(-135.9%) | -$34.61 M(-44.9%) |
| Sept 2022 | - | -$4.96 M(-59.2%) | -$62.80 M(+0.5%) |
| June 2022 | - | -$12.15 M(-37.0%) | -$62.48 M(-5.3%) |
| Mar 2022 | - | -$19.28 M(-27.0%) | -$65.95 M(+49.4%) |
| Dec 2021 | -$44.14 M(+167.3%) | -$26.41 M(+470.1%) | -$44.14 M(+151.5%) |
| Sept 2021 | - | -$4.63 M(-70.3%) | -$17.55 M(+69.7%) |
| June 2021 | - | -$15.62 M(-717.4%) | -$10.35 M(+68.3%) |
| Mar 2021 | - | $2.53 M(+1370.9%) | -$6.15 M(-62.8%) |
| Dec 2020 | -$16.51 M(-202.4%) | $172.00 K(-93.3%) | -$16.51 M(-23.1%) |
| Sept 2020 | - | $2.57 M(-122.5%) | -$21.46 M(+28.2%) |
| June 2020 | - | -$11.42 M(+45.9%) | -$16.74 M(-516.6%) |
| Mar 2020 | - | -$7.83 M(+63.8%) | $4.02 M(-75.1%) |
| Dec 2019 | $16.12 M(-53.7%) | -$4.78 M(-165.6%) | $16.12 M(-49.4%) |
| Sept 2019 | - | $7.29 M(-21.9%) | $31.87 M(-8.2%) |
| June 2019 | - | $9.34 M(+118.6%) | $34.71 M(+6.5%) |
| Mar 2019 | - | $4.27 M(-61.0%) | $32.60 M(-6.3%) |
| Dec 2018 | $34.81 M(+22.6%) | $10.97 M(+8.2%) | $34.81 M(+11.5%) |
| Sept 2018 | - | $10.13 M(+40.1%) | $31.22 M(+2.3%) |
| June 2018 | - | $7.23 M(+11.7%) | $30.51 M(+0.9%) |
| Mar 2018 | - | $6.48 M(-12.2%) | $30.25 M(+6.6%) |
| Dec 2017 | $28.38 M(+41.9%) | $7.38 M(-21.7%) | $28.38 M(+27.5%) |
| Sept 2017 | - | $9.43 M(+35.1%) | $22.26 M(+7.4%) |
| June 2017 | - | $6.97 M(+51.4%) | $20.74 M(+9.5%) |
| Mar 2017 | - | $4.61 M(+267.1%) | $18.94 M(-5.3%) |
| Dec 2016 | $20.00 M(-38.9%) | $1.25 M(-84.1%) | $20.00 M(-20.0%) |
| Sept 2016 | - | $7.90 M(+52.5%) | $25.02 M(-2.0%) |
| June 2016 | - | $5.18 M(-8.6%) | $25.54 M(-11.2%) |
| Mar 2016 | - | $5.67 M(-9.6%) | $28.77 M(-12.1%) |
| Dec 2015 | $32.74 M(+62.4%) | $6.27 M(-25.6%) | $32.74 M(-12.5%) |
| Sept 2015 | - | $8.42 M(+0.1%) | $37.40 M(+0.6%) |
| June 2015 | - | $8.41 M(-12.7%) | $37.18 M(+41.3%) |
| Mar 2015 | - | $9.63 M(-11.9%) | $26.31 M(+30.3%) |
| Dec 2014 | $20.17 M(+3300.7%) | $10.93 M(+33.3%) | $20.20 M(+62.6%) |
| Sept 2014 | - | $8.20 M(-433.3%) | $12.42 M(+146.9%) |
| June 2014 | - | -$2.46 M(-169.8%) | $5.03 M(+35.4%) |
| Mar 2014 | - | $3.52 M(+11.7%) | $3.71 M(-282.4%) |
| Dec 2013 | $593.00 K(-102.2%) | $3.15 M(+289.5%) | -$2.04 M(-77.7%) |
| Sept 2013 | - | $810.00 K(-121.5%) | -$9.11 M(-43.4%) |
| June 2013 | - | -$3.77 M(+69.6%) | -$16.10 M(-17.8%) |
| Mar 2013 | - | -$2.23 M(-43.3%) | -$19.59 M(-28.8%) |
| Dec 2012 | -$27.49 M(-46.0%) | -$3.92 M(-36.5%) | -$27.51 M(-8.5%) |
| Sept 2012 | - | -$6.18 M(-15.0%) | -$30.07 M(-17.5%) |
| June 2012 | - | -$7.27 M(-28.3%) | -$36.45 M(-13.7%) |
| Mar 2012 | - | -$10.14 M(+56.4%) | -$42.25 M(-14.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | -$50.93 M(+11.9%) | -$6.48 M(-48.4%) | -$49.19 M(-14.9%) |
| Sept 2011 | - | -$12.56 M(-3.9%) | -$57.77 M(+2.3%) |
| June 2011 | - | -$13.06 M(-23.5%) | -$56.45 M(+5.3%) |
| Mar 2011 | - | -$17.08 M(+13.3%) | -$53.63 M(+17.8%) |
| Dec 2010 | -$45.51 M(+18.4%) | -$15.07 M(+34.1%) | -$45.51 M(-17.7%) |
| Sept 2010 | - | -$11.24 M(+9.8%) | -$55.28 M(+13.0%) |
| June 2010 | - | -$10.24 M(+14.3%) | -$48.94 M(+13.0%) |
| Mar 2010 | - | -$8.96 M(-63.9%) | -$43.32 M(+12.7%) |
| Dec 2009 | -$38.43 M(+113.3%) | -$24.84 M(+407.0%) | -$38.43 M(+148.8%) |
| Sept 2009 | - | -$4.90 M(+6.0%) | -$15.44 M(-10.4%) |
| June 2009 | - | -$4.62 M(+13.7%) | -$17.23 M(-4.9%) |
| Mar 2009 | - | -$4.06 M(+118.5%) | -$18.13 M(+0.5%) |
| Dec 2008 | -$18.01 M(+107.5%) | -$1.86 M(-72.2%) | -$18.03 M(-0.8%) |
| Sept 2008 | - | -$6.69 M(+21.3%) | -$18.18 M(+33.3%) |
| June 2008 | - | -$5.51 M(+39.0%) | -$13.64 M(+26.8%) |
| Mar 2008 | - | -$3.97 M(+97.1%) | -$10.76 M(+24.0%) |
| Dec 2007 | -$8.68 M(-352.3%) | -$2.01 M(-6.3%) | -$8.68 M(-366.2%) |
| Sept 2007 | - | -$2.15 M(-18.4%) | $3.26 M(-28.2%) |
| June 2007 | - | -$2.63 M(+39.3%) | $4.54 M(-6.9%) |
| Mar 2007 | - | -$1.89 M(-119.0%) | $4.88 M(+41.8%) |
| Dec 2006 | $3.44 M(-137.0%) | $9.93 M(-1244.3%) | $3.44 M(-141.5%) |
| Sept 2006 | - | -$867.50 K(-62.2%) | -$8.28 M(-11.6%) |
| June 2006 | - | -$2.30 M(-31.0%) | -$9.37 M(-4.0%) |
| Mar 2006 | - | -$3.32 M(+85.5%) | -$9.76 M(+4.9%) |
| Dec 2005 | -$9.30 M(-24.2%) | -$1.79 M(-8.4%) | -$9.30 M(-20.6%) |
| Sept 2005 | - | -$1.96 M(-27.1%) | -$11.72 M(-7.8%) |
| June 2005 | - | -$2.68 M(-6.4%) | -$12.72 M(+0.4%) |
| Mar 2005 | - | -$2.87 M(-31.9%) | -$12.66 M(+3.2%) |
| Dec 2004 | -$12.27 M(+102.9%) | -$4.21 M(+42.5%) | -$12.27 M(+25.1%) |
| Sept 2004 | - | -$2.95 M(+12.3%) | -$9.80 M(+18.3%) |
| June 2004 | - | -$2.63 M(+6.4%) | -$8.29 M(+13.8%) |
| Mar 2004 | - | -$2.47 M(+41.6%) | -$7.29 M(+20.3%) |
| Dec 2003 | -$6.05 M(+58.7%) | -$1.75 M(+21.4%) | -$6.06 M(+28.3%) |
| Sept 2003 | - | -$1.44 M(-11.6%) | -$4.72 M(+15.6%) |
| June 2003 | - | -$1.63 M(+30.8%) | -$4.08 M(+3.2%) |
| Mar 2003 | - | -$1.24 M(+202.6%) | -$3.96 M(+3.7%) |
| Dec 2002 | -$3.81 M(+36.8%) | -$411.40 K(-48.6%) | -$3.82 M(-21.2%) |
| Sept 2002 | - | -$801.00 K(-46.7%) | -$4.85 M(+28.9%) |
| June 2002 | - | -$1.50 M(+36.2%) | -$3.76 M(+20.6%) |
| Mar 2002 | - | -$1.10 M(-23.4%) | -$3.12 M(+13.9%) |
| Dec 2001 | -$2.79 M(-19.0%) | -$1.44 M(-603.1%) | -$2.73 M(+34.1%) |
| Sept 2001 | - | $286.30 K(-133.3%) | -$2.04 M(-32.2%) |
| June 2001 | - | -$858.90 K(+19.0%) | -$3.01 M(-16.1%) |
| Mar 2001 | - | -$722.00 K(-3.0%) | -$3.58 M(+6.1%) |
| Dec 2000 | -$3.44 M(+114.2%) | -$744.40 K(+9.3%) | -$3.38 M(+28.3%) |
| Sept 2000 | - | -$680.90 K(-52.5%) | -$2.63 M(+34.9%) |
| June 2000 | - | -$1.43 M(+177.8%) | -$1.95 M(+131.5%) |
| Mar 2000 | - | -$516.20 K(+58.2%) | -$842.40 K(+158.2%) |
| Dec 1999 | -$1.60 M(-39.7%) | - | - |
| June 1999 | - | -$326.20 K | -$326.20 K |
| Dec 1998 | -$2.66 M | - | - |
FAQ
- What is ANI Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals annual EBIT year-on-year change?
- What is ANI Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals quarterly EBIT year-on-year change?
- What is ANI Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for ANI Pharmaceuticals?
- What is ANI Pharmaceuticals TTM EBIT year-on-year change?
What is ANI Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of ANIP is $46.81 M
What is the all time high annual EBIT for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high annual earnings before interest & taxes is $106.60 M
What is ANI Pharmaceuticals annual EBIT year-on-year change?
Over the past year, ANIP annual earnings before interest & taxes has changed by +$81.42 M (+235.24%)
What is ANI Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of ANIP is -$29.17 M
What is the all time high quarterly EBIT for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high quarterly earnings before interest & taxes is $29.93 M
What is ANI Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, ANIP quarterly earnings before interest & taxes has changed by -$47.08 M (-262.86%)
What is ANI Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of ANIP is $9.83 M
What is the all time high TTM EBIT for ANI Pharmaceuticals?
ANI Pharmaceuticals all-time high TTM earnings before interest & taxes is $66.89 M
What is ANI Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, ANIP TTM earnings before interest & taxes has changed by -$32.07 M (-76.54%)